XML 31 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense included in costs and expenses
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
    (in thousands)  
Share-based compensation expense:                        
Cost of revenues   $ 19     $ 14     $ 39     $ 28  
Sales and marketing [1]     402       341       814       974  
Technology support [2]     134       98       262       429  
General and administrative     389       418       841       807  
Share-based compensation costs     944       871       1,956       2,238  
                                 
Amount capitalized to internal use software           5       1       8  
Total share-based compensation costs   $ 944     $ 866     $ 1,955     $ 2,230  
Service based options granted during period
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
                         
Number of service-based options granted     54,000       62,500       373,250       491,400  
Weighted average grant date fair value   $ 6.56     $ 6.75     $ 6.86     $ 7.94  
Weighted average exercise price   $ 13.05     $ 14.18     $ 13.70     $ 16.75  
Stock option exercises
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
                         
Number of stock options exercised     117,115       104,634       176,074       158,473  
Weighted average exercise price   $ 4.67     $ 7.35     $ 5.70     $ 9.26  
Fair value of stock options granted using the following weighted average assumptions
   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2017     2016     2017     2016  
                         
Dividend yield                        
Volatility     62 %     59 %     61 %     58 %
Risk-free interest rate     1.7 %     1.1 %     1.8 %     1.3 %
Expected life (years)     4.4       4.4       4.4       4.4